INVERNESS MEDICAL TECHNOLOGY INC/DE
S-4, EX-23.5, 2000-12-04
LABORATORY ANALYTICAL INSTRUMENTS
Previous: INVERNESS MEDICAL TECHNOLOGY INC/DE, S-4, EX-23.2, 2000-12-04
Next: INVERNESS MEDICAL TECHNOLOGY INC/DE, S-4, EX-99.2, 2000-12-04



<PAGE>

                                                                  Exhibit 23.5

                   CONSENT OF U.S. BANCORP PIPER JAFFRAY INC.



We hereby consent to the inclusion in the Registration Statement on Form S-4 of
Inverness Medical Technology, Inc. ("Inverness") relating to the proposed merger
of Integ Incorporated with and into a wholly owned subsidiary of Inverness of
our opinion letter, dated October 3, 2000, appearing as Annex B to the Proxy
Statement and Prospectus which is a part of the Registration Statement, and to
the references of our firm name therein. In giving such consent, we do not
thereby admit that we come within the category of person whose consent is
required under Section 7 or Section 11 of the Securities Act of 1933, as
amended, or the rules and regulations adopted by the Securities and Exchange
Commission thereunder, nor do we admit that we are experts with respect to any
part of such Registration Statement within the meaning of the term "experts" as
used in the Securities Act of 1933, as amended, or the rules and regulations of
the Securities and Exchange Commission thereunder.

Very truly yours,



By /s/ U.S. Bancorp Piper Jaffray
   ---------------------------------------------
       U.S. Bancorp Piper Jaffray Inc.



Minneapolis, Minnesota
November   , 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission